Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura

Immune-mediated thrombotic thrombocytopenic purpura is characterized by severe thrombocytopenia and microangiopathic hemolytic anemia. It is primarily caused by immunoglobin G type autoantibodies against ADAMTS13, a plasma metalloprotease that cleaves von Willebrand factor. However, reliable markers...

Descripción completa

Detalles Bibliográficos
Autores principales: Staley, Elizabeth M., Cao, Wenjing, Pham, Huy P., Kim, Chong H., Kocher, Nicole K., Zheng, Lucy, Gangaraju, Radhika, Lorenz, Robin G., Williams, Lance A., Marques, Marisa B., Zheng, X. Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312039/
https://www.ncbi.nlm.nih.gov/pubmed/30171022
http://dx.doi.org/10.3324/haematol.2018.198275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312039/
https://www.ncbi.nlm.nih.gov/pubmed/30171022
http://dx.doi.org/10.3324/haematol.2018.198275

Ejemplares similares